
<p>Pertuzumab in the treatment of HER2-positive breast cancer: an evidence-based review of its safety, efficacy, and place in therapy</p>
Author(s) -
Kei Ishii,
Nao Morii,
Hiroyasu Yamashiro
Publication year - 2019
Publication title -
core evidence
Language(s) - English
Resource type - Journals
eISSN - 1555-175X
pISSN - 1555-1741
DOI - 10.2147/ce.s217848
Subject(s) - pertuzumab , medicine , trastuzumab , breast cancer , oncology , cancer , clinical trial , metastatic breast cancer